Webinar
On demand

Cooley Rx series

Life Sciences Litigation: IPRs, Preliminary Injunctions and Trials

November 19, 2024
Event details
November 19, 2024
12:00 – 1:00 pm Eastern Daylight Time

Event summary

Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. We discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.

This virtual event provided an in-depth look at how inter partes review (IPR) proceedings impact parallel district court litigation, including how these proceedings come into evidence during preliminary injunctions (PIs) and trials, and how the pendency of IPRs can affect PI and trial outcomes, particularly in life sciences patent litigation.

Life Sciences Litigation: IPRs, Preliminary Injunctions and Trials

Cooley life sciences intellectual property litigation partners Orion Armon and Eamonn Gardner answered the following questions:

  • What IPR information can come into evidence during a PI proceeding or at trial, and on what issues?
  • How can pending IPR proceedings affect PI and trial outcomes?
  • What types of work-arounds can be used when IPRs are excluded from evidence? 

Credits

  • Attendees may earn up to 1.0 continuing legal education (CLE) credit for participating in this live webinar. Credit will not be granted for on-demand viewing.
  • Cooley LLP is an approved provider and will provide credit in CA, CO, IL, NY, PA and TX.
  • Cooley LLP is a sponsor and will apply for credit in FL, OH, VA and WA.
  • Credit in other jurisdictions may be available via reciprocity.
  • If you have specific CLE credit questions, please contact Cooley’s licensing and compliance team.

 

For more information, please email Megan Senerchia.

On demand

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.